Why Patients Consider Switching From Wegovy To Mounjaro
Online Prescription Process for Switching From Wegovy to Mounjaro
Switching from Wegovy to Mounjaro requires a comprehensive online clinical assessment that takes just 3 minutes to complete. Our assessment covers your current Wegovy experience, medical history, BMI calculations, and any contraindications that might influence your switch to tirzepatide. Unlike traditional GP appointments that can take weeks to secure, our online process removes barriers whilst maintaining clinical safety standards. Licensed UK prescribers review every case individually, ensuring your switch from Wegovy to Mounjaro is clinically appropriate for your circumstances.
The assessment process specifically addresses why you're considering switching from Wegovy to Mounjaro, whether due to side effects, efficacy concerns, or preference for Mounjaro's dual-action mechanism. Our prescribers evaluate your weight management journey, current dose tolerance, and individual risk factors before approving any prescription-only medicine. Standard prescriber review takes 3 working days, though express 24-hour review is available for urgent switches. Once approved, your Mounjaro prescription is dispatched via temperature-controlled next-day delivery from our GPhC-registered facility (#9012878).
Pricing and Value When Switching From Wegovy to Mounjaro
Understanding the cost implications of switching from Wegovy to Mounjaro helps inform your decision-making process. Mounjaro follows a similar dose-escalation schedule, starting at £89.99 for the 2.5mg starter dose, progressing through 5mg (£94.99), 7.5mg (£99.99), 10mg (£139.99), to maintenance doses of 12.5mg or 15mg (£209.99). New customers benefit from code FIRST40 applied at checkout, whilst returning customers use code DOSE25 for ongoing savings. Both medications require gradual dose increases over 16-20 weeks, making bundle options particularly valuable for ensuring consistent supply during your transition.
When switching from Wegovy to Mounjaro, many patients choose our step-up bundles to secure multiple doses at once, avoiding repeated orders during the critical transition period. Our Mounjaro Intro Trio bundle provides the first three doses (2.5mg, 5mg, 7.5mg) for £299.99, covering your initial 12 weeks after switching. The convenience of Reliable Supply proves invaluable when switching between prescription-only medicines, as supply interruptions can disrupt your weight management progress. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which medication suits your individual needs and budget.
Clinical Evidence Supporting Switching From Wegovy to Mounjaro
Patients considering switching from Wegovy to Mounjaro often want to understand the clinical differences between semaglutide and tirzepatide. Wegovy (semaglutide) demonstrated significant efficacy in the STEP trials, with participants achieving approximately 15% average weight loss alongside diet and exercise over 68 weeks (Wilding et al., NEJM, 2021). Mounjaro's SURMOUNT trials showed tirzepatide's dual-action mechanism targeting both GLP-1 and GIP receptors may offer different benefits for certain patients. However, trial populations, endpoints, and methodologies differ significantly, making direct head-to-head comparisons inappropriate.
The decision to switch from Wegovy to Mounjaro should be based on individual clinical factors rather than trial comparisons alone. Some patients find tirzepatide's mechanism suits their physiology better, whilst others prefer semaglutide's established track record. Both prescription-only medicines require ongoing commitment to reduced-calorie diet and increased physical activity for optimal results. Your prescriber can evaluate your Wegovy experience and determine whether switching to Mounjaro aligns with your weight management goals and clinical profile.
How Wegovy Works vs Mounjaro's Mechanism
Understanding the mechanistic differences helps explain why some patients benefit from switching from Wegovy to Mounjaro. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone, promoting satiety and reducing appetite through brain appetite centres. Mounjaro (tirzepatide) acts as a dual agonist, targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual-action approach may provide different appetite control and metabolic effects compared to Wegovy's single-pathway mechanism. Both medications slow gastric emptying, helping you feel fuller for longer after meals. The choice between single-pathway (Wegovy) and dual-pathway (Mounjaro) approaches depends on individual response and tolerability factors that your prescriber can assess.
Streamlined Ordering Process for Your Switch
Switching from Wegovy to Mounjaro through EverydayMeds follows a straightforward process designed to minimise disruption to your treatment. Complete our 3-minute clinical assessment covering your current Wegovy experience, reasons for switching, and medical suitability for tirzepatide. Licensed UK prescribers review your assessment within 3 working days (or 24 hours with express service), evaluating whether switching to Mounjaro is clinically appropriate. Once approved, your prescription-only medicine is prepared in our temperature-controlled facility and dispatched via next-day delivery. Our cold-chain logistics ensure Mounjaro maintains its required 2-8°C storage temperature throughout transit, arriving ready for refrigerated storage.
Storage and Practical Considerations
Practical differences between medications often influence the decision when switching from Wegovy to Mounjaro. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use and come in pre-filled injection pens for once-weekly administration. Wegovy uses Novo Nordisk's FlexTouch pen system, whilst Mounjaro employs Eli Lilly's KwikPen technology – both designed for easy self-injection. Dose escalation schedules differ slightly, with Wegovy following a 16-week escalation to 2.4mg maintenance, whilst Mounjaro escalates over 20 weeks to 15mg maintenance. Consider these practical factors alongside clinical considerations when switching between these prescription-only medicines.
Personalised Prescriber Guidance for Switching From Wegovy to Mounjaro
Every patient considering switching from Wegovy to Mounjaro receives individualised prescriber evaluation through our online service. Our licensed UK prescribers assess your specific reasons for switching, whether related to side effects, efficacy, convenience factors, or clinical progression needs. This personalised approach ensures your switch to Mounjaro is medically appropriate rather than based solely on general comparison information. Your prescriber may recommend specific timing for the switch, washout periods, or dose adjustments based on your Wegovy experience.
The beauty of switching from Wegovy to Mounjaro through our online service lies in the continuity of care without traditional healthcare barriers. Your prescriber maintains oversight of your weight management journey, whether you continue with Wegovy or transition to Mounjaro's dual-action mechanism. Both medications are available through our GPhC-registered pharmacy (#9012878), ensuring consistent quality, storage standards, and delivery reliability regardless of your final choice.
Complete Your Switch With Confidence
Ready to explore switching from Wegovy to Mounjaro with professional prescriber support? Our 3-minute clinical assessment evaluates your individual needs, current treatment experience, and suitability for tirzepatide therapy. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 for ongoing value. Licensed UK prescribers provide the clinical oversight necessary when switching between prescription-only medicines, ensuring your transition supports your long-term weight management goals. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment today, or explore our Mounjaro options with the same clinical standards and convenience. Both medications require commitment to reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
